Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Papillomavirus Infections 2Breast Neoplasms 2Acquired Immunodeficiency Syndrome 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Sexually Transmitted Diseases 1Ovarian Cysts 1Neoplasms 1Menorrhagia 1Lung Neoplasms 1Leiomyoma 1High-grade Anal Intraepithelial Neoplasia 1HIV Infections 1Endometriosis 1Condylomata Acuminata 1Benign Ovarian Tumor 1Anus Neoplasms 1

Interventions

Fluorouracil 26Radiotherapy 18Mitomycin 17Cisplatin 12Capecitabine 12pembrolizumab 10Magnetic Resonance Spectroscopy 9Cyclophosphamide 9Radiation 8Paclitaxel 8Biopsy 8fludarabine 7Specimen Handling 7Nivolumab 7Drug Therapy 7Carboplatin 7Surveys and Questionnaires 6Cetuximab 6Papillomavirus Vaccines 5dehydroftorafur 4aldesleukin 4Vaccines 4Radiotherapy, Intensity-Modulated 4Observation 4Irinotecan 4Watchful Waiting 3Taxes 3Oxaliplatin 3Light Coagulation 3Ipilimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × Electrocoagulation × Clear all
NCT02615860 2022-11-08

TECAIN

University Hospital, Essen

Phase NA Completed
560 enrolled
Gastrointestinal

Acquired Immunodeficiency Syndrome, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡